In Vivo is part of Pharma Intelligence UK Limited

This site is operated by Pharma Intelligence UK Limited, a company registered in England and Wales with company number 13787459 whose registered office is 5 Howick Place, London SW1P 1WG. The Pharma Intelligence group is owned by Caerus Topco S.à r.l. and all copyright resides with the group.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
Brought to you by

King raises $165mm

Executive Summary

King Pharmaceuticals (acquires and inlicenses branded pharmaceuticals in niche markets) netted $165.5mm in a follow-on offering of 4mm common shares at $41.38 each. All of the shares were purchased by Donaldson, Lufkin, and Jenrette, which will offer them for resale.

Deal Industry
  • Pharmaceuticals
Deal Status
  • Final
Deal Type
  • Financing
    • Private Placement

Related Companies

UsernamePublicRestriction

Register